Keywords: 3m, aldara, delayed, skin, cancer, pharmaceuticals, says

3M's Aldara delayed for skin cancer

Article | 19 April 2004

Print This

3M Pharmaceuticals says that it has received an approvable letter from the US Food and Drug Administration in response to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in